Omeprazole Clinical Trials

5 actively recruiting trials across 4 locations

Also known as: Prilosec

Pipeline

Early 1: 2Phase 1: 3

Top Sponsors

University of Oklahoma1
University of Michigan Rogel Cancer Center1
Murdoch Childrens Research Institute1
Gilead Sciences1
Genentech, Inc.1

Indications

Cancer4
Weight Management1
Exocrine Pancreatic Cancer1
Diabetes1
Colorectal Neoplasia1

Other1 trial

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

Phase 1

Miami, Florida1 trial

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Qps-Mra, Llc.

Phase 1

Ann Arbor, Michigan1 trial

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

The University of Michigan Rogel Cancer Center

Early 1

Grand Rapids, Michigan1 trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

START - Midwest - EDOS

Phase 1

Oklahoma City, Oklahoma1 trial

High Dose Omeprazole in Patients With Pancreatic Cancer

Stephenson Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.